NAYA Biosciences, Financials
| NAYA Stock | 0.98 0.04 4.26% |
NAYA |
Understanding current and past NAYA Biosciences, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NAYA Biosciences,'s financial statements are interrelated, with each one affecting the others. For example, an increase in NAYA Biosciences,'s assets may result in an increase in income on the income statement.
Please note, the presentation of NAYA Biosciences,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NAYA Biosciences,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NAYA Biosciences,'s management manipulating its earnings.
NAYA Biosciences, Stock Summary
NAYA Biosciences, competes with Origin Materials, NL Industries, Datadog, Sealed Air, and Q2 Holdings. NAYA Biosciences, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Medical Devices |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 44984F302 44984F401 44984F104 44984F203 |
| Older Symbol | INVO |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
NAYA Biosciences, Systematic Risk
NAYA Biosciences,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NAYA Biosciences, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on NAYA Biosciences, correlated with the market. If Beta is less than 0 NAYA Biosciences, generally moves in the opposite direction as compared to the market. If NAYA Biosciences, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NAYA Biosciences, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NAYA Biosciences, is generally in the same direction as the market. If Beta > 1 NAYA Biosciences, moves generally in the same direction as, but more than the movement of the benchmark.
About NAYA Biosciences, Financials
What exactly are NAYA Biosciences, Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include NAYA Biosciences,'s income statement, its balance sheet, and the statement of cash flows. Potential NAYA Biosciences, investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although NAYA Biosciences, investors may use each financial statement separately, they are all related. The changes in NAYA Biosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NAYA Biosciences,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.NAYA Biosciences, November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NAYA Biosciences, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NAYA Biosciences,. We use our internally-developed statistical techniques to arrive at the intrinsic value of NAYA Biosciences, based on widely used predictive technical indicators. In general, we focus on analyzing NAYA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NAYA Biosciences,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 5.47 | |||
| Information Ratio | 0.0526 | |||
| Maximum Drawdown | 105.62 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 8.96 |
Complementary Tools for NAYA Stock analysis
When running NAYA Biosciences,'s price analysis, check to measure NAYA Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NAYA Biosciences, is operating at the current time. Most of NAYA Biosciences,'s value examination focuses on studying past and present price action to predict the probability of NAYA Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NAYA Biosciences,'s price. Additionally, you may evaluate how the addition of NAYA Biosciences, to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |